Aldo Maggioni

Professor Aldo Maggioni is Director of the Research Center of the Italian Association of Hospital Cardiologists (ANMCO) in Florence. He is also a member of the coordinating center of the GISSI studies (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico) in collaboration with the Mario Negri Institute for Pharmacological Research in Milan.

Professor Maggioni received his medical degree in 1974 from the University of Milan School of Medicine, Italy, where he subsequently completed his fellowship in internal medicine. He undertook a residency in cardiology at the University of Padua (1975-1978) before becoming a clinical cardiologist at the General Hospital ‘G. Fornaroli’ and progressing to Vice-Head of the Division of  Cardiology at G. Fornaroli and, later, of the Division of Cardiology at the General Hospital Fatebenefratelli ed Oftalmico, both in Milan. He was Secretary of the Heart Failure Association and Scientific Coordinator of the EORP registries of the ESC (2010 up to date).

Professor Maggioni’s professional and research interests include clinical trial methodology, controlled evaluation of fibrinolytic and antithrombotic agents, management of acute myocardial infarction and chronic heart failure, clinical epidemiology of myocardial infarction and heart failure, and appropriateness of use of resources in cardiovascular diseases.

Professor Maggioni has served on the steering committees, event evaluation committees, and data and safety monitoring boards of more than 50 clinical trials in the fields of arrhythmia, myocardial infarction, unstable angina, secondary prevention, stroke, and congestive heart failure.

Professor Maggioni is the author of almost 500 papers in peer-reviewed journals. He is also a member of the editorial board of the following journals: Journal of Cardiovascular Medicine, Cardiovascular Drugs and Therapeutics, Evidence-based Cardiovascular Medicine, European Heart Journal, and European Journal of Heart Failure. He has been also included in the list of the highly cited researchers over the last 13 years (2003-2015) by Thomson Reuters.